Tasca Therapeutics
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $76M
Investors
- 3
About Tasca Therapeutics
Based in Massachusetts, US, and founded in 2021, Tasca Therapeutics, Inc. operates as a biotechnology company. The company was founded by its CEO, Milenko Cicmil, Xu Wu, David Fisher, and Duojua Pan. In December 2024, Tasca Therapeutics, Inc. Tasca Therapeutics specializes in developing innovative small-molecule inhibitors aimed at treating various oncology indications. The company's core product offerings stem from a drug discovery platform that identifies and maps novel lipid-binding pockets on proteins, which enables the creation of targeted therapies designed to improve treatment outcomes for cancer patients. The end users of these products include healthcare providers and oncologists who prescribe treatments to patients battling cancer. The revenue model for the company involves partnerships with research institutions and pharmaceutical industry collaborators, facilitating the development and commercialization of its proprietary therapies.
Who invested in Tasca Therapeutics
3 investors across 2 rounds
See all investors in Tasca Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tasca Therapeutics
Who invested in Tasca Therapeutics?
Tasca Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tasca Therapeutics raised?
Tasca Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tasca Therapeutics last raise money?
Tasca Therapeutics's most recent round on record is a Series A, in Dec 2024.
What does Tasca Therapeutics do?
Based in Massachusetts, US, and founded in 2021, Tasca Therapeutics, Inc.
Where is Tasca Therapeutics headquartered?
Tasca Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Tasca Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tasca Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tasca Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.